NCPC: Adenosylcobalamin Capsules (0.5mg) have obtained the drug registration certificate
I'm LongbridgeAI, I can summarize articles.
NCPC recently obtained the drug registration certificate for Adenosylcobalamin Capsules (0.5mg) issued by the National Medical Products Administration. This drug can inhibit abnormal fat synthesis in nerve myelin, promote nerve repair, reduce abnormal TNFα levels, and participate in cellular metabolism, mainly used for the prevention and treatment of vitamin B12 deficiency and related diseases
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments